This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Segura, M Articles by Sitges-Serra, A Search for Related Content PubMed PubMed Citation Articles by Segura, M Articles by Sitges-Serra, A

 Previous Article  |  Next Article 

J Clin Microbiol. 1989 December; 27(12): 2656-2659

In vitro bacteriological study of a new hub model for intravascular catheters and infusion equipment.

Department of Surgery, Hospital Universitari Nostra Senyora del Mar, Spain.

ABSTRACT

We investigated in vitro the antibacterial properties of a simulated new hub model in which the female part has an antiseptic chamber through which the needle (male part) must pass before connection of the set and the catheter. To establish the time needed for disinfection, the magnitude of reduction of the contaminating inocula by the new hub model, and the antibacterial properties of the different components of the hub, we used needles contaminated with solutions containing high inocula (1.9 x 10(7) to 1.2 x 10(11) CFU/ml) of microorganisms involved in hub-related catheter sepsis. Sterilization of the needles was accomplished by allowing them to remain in the antiseptic chamber for 10 s in all assays with Staphylococcus epidermidis, Pseudomonas aeruginosa, Escherichia coli, and Candida albicans. The rubber closures limiting the antiseptic chamber and the dilution effect of the antiseptic itself accounted for a minor part of the inoculum reduction achieved by the new hub model. This simulated hub provides good protection against endoluminal contamination. Further studies seem warranted to prove its industrial viability and clinical efficacy.